• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性睾丸癌化疗后的残留肿块:腹膜后和肺部组织学关联的临床意义。睾丸癌组织学再分析(ReHiT)研究组

Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.

作者信息

Steyerberg E W, Donohue J P, Gerl A, Toner G C, Schraffordt Koops H, Fosså S D, Keizer H J

机构信息

Department of Public Health, Erasmus University, Rotterdam, The Netherlands.

出版信息

J Urol. 1997 Aug;158(2):474-8. doi: 10.1016/s0022-5347(01)64506-3.

DOI:10.1016/s0022-5347(01)64506-3
PMID:9224327
Abstract

PURPOSE

We determined the need and sequence of retroperitoneal lymph node dissection and thoracotomy in patients with nonseminomatous testicular cancer, and with residual retroperitoneal and pulmonary masses after chemotherapy.

MATERIALS AND METHODS

We studied 159 patients undergoing retroperitoneal lymph node dissection and a thoracotomy following cisplatin based induction chemotherapy for metastatic testicular nonseminomatous germ cell tumor. Several well-known predictors for residual histology (necrosis, mature teratoma and cancer) were evaluated.

RESULTS

As expected, necrosis was found more often at retroperitoneal lymph node dissection if the primary tumor was negative for teratoma, the residual mass was small or the decrease in size was great. Contrary, neither residual mass size nor the decrease in size was predictive of the histological status of the residual lung lesion. Histological findings in the retroperitoneum and lung were strongly correlated, such that necrosis at retroperitoneal lymph node dissection was associated with an 89% probability of necrosis in the lung.

CONCLUSIONS

Retroperitoneal lymph node dissection should be performed before thoracotomy is considered, since the histological status at dissection is a strong predictor of that at thoracotomy.

摘要

目的

我们确定了非精原细胞瘤性睾丸癌患者以及化疗后有腹膜后和肺部残留肿块患者进行腹膜后淋巴结清扫术和开胸手术的必要性及顺序。

材料与方法

我们研究了159例接受基于顺铂的诱导化疗治疗转移性睾丸非精原细胞瘤性生殖细胞肿瘤后进行腹膜后淋巴结清扫术和开胸手术的患者。评估了几种众所周知的残留组织学(坏死、成熟畸胎瘤和癌)预测指标。

结果

正如预期的那样,如果原发肿瘤为畸胎瘤阴性、残留肿块较小或缩小幅度较大,则在腹膜后淋巴结清扫术中更常发现坏死。相反,残留肿块大小和缩小幅度均不能预测残留肺部病变的组织学状态。腹膜后和肺部的组织学发现密切相关,以至于腹膜后淋巴结清扫术中的坏死与肺部坏死的概率为89%相关。

结论

应在考虑开胸手术之前进行腹膜后淋巴结清扫术,因为清扫术中的组织学状态是开胸手术组织学状态的有力预测指标。

相似文献

1
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.转移性睾丸癌化疗后的残留肿块:腹膜后和肺部组织学关联的临床意义。睾丸癌组织学再分析(ReHiT)研究组
J Urol. 1997 Aug;158(2):474-8. doi: 10.1016/s0022-5347(01)64506-3.
2
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.转移性非精原细胞性生殖细胞肿瘤化疗后的残留肺部肿块。组织学预测。ReHiT研究组。
Cancer. 1997 Jan 15;79(2):345-55.
3
Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.转移性非精原细胞性生殖细胞肿瘤化疗后不同部位残留肿块切除的组织学结果比较。
Eur J Cancer. 1997 May;33(6):843-7. doi: 10.1016/s0959-8049(96)00517-5.
4
Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified.开胸手术用于非精原细胞瘤性睾丸生殖细胞肿瘤患者化疗后肺部残留肿瘤块的切除:积极的手术切除是合理的。
Chest. 1997 Oct;112(4):967-73. doi: 10.1378/chest.112.4.967.
5
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.转移性睾丸非精原细胞瘤患者化疗后残留肿块的切除及有限的腹膜后淋巴结清扫术。
Cancer. 1994 Aug 15;74(4):1329-34. doi: 10.1002/1097-0142(19940815)74:4<1329::aid-cncr2820740424>3.0.co;2-l.
6
Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.睾丸癌残留腹膜后肿块切除术:选择标准的评估与改进。ReHiT研究组。睾丸癌组织学再分析。
Br J Cancer. 1996 Nov;74(9):1492-8. doi: 10.1038/bjc.1996.571.
7
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.非精原细胞瘤性睾丸癌中残留腹膜后肿块组织学预测的有效性
J Clin Oncol. 1998 Jan;16(1):269-74. doi: 10.1200/JCO.1998.16.1.269.
8
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.睾丸切除标本中的畸胎瘤及转移灶体积是化疗后非精原细胞瘤性睾丸癌腹膜后畸胎瘤的预测指标。
J Urol. 2002 Oct;168(4 Pt 1):1402-4. doi: 10.1016/S0022-5347(05)64458-8.
9
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.转移性非精原细胞瘤性生殖细胞肿瘤化疗后腹膜后残留肿块组织学的预测:来自六个研究组的个体患者数据的多变量分析
J Clin Oncol. 1995 May;13(5):1177-87. doi: 10.1200/JCO.1995.13.5.1177.
10
Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.晚期睾丸癌患者化疗后延迟睾丸切除术
Int Urol Nephrol. 2001;32(4):665-7. doi: 10.1023/a:1014466110566.

引用本文的文献

1
Discordance of retroperitoneal and thoracic histologic findings in patients with metastatic germ cell tumors at postchemotherapy residual tumor resection.化疗后残余肿瘤切除术后转移性生殖细胞肿瘤患者的腹膜后和胸部组织学检查结果不一致。
World J Surg Oncol. 2024 Jul 17;22(1):185. doi: 10.1186/s12957-024-03467-6.
2
Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.加拿大泌尿外科学会共识指南:睾丸生殖细胞癌的管理
Can Urol Assoc J. 2022 Jun;16(6):155-173. doi: 10.5489/cuaj.7945.
3
Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor.
非精原细胞性生殖细胞肿瘤患者行肝肿块切除联合腹膜后淋巴结清扫术后的组织学和肿瘤学结果
Urology. 2018 Aug;118:114-118. doi: 10.1016/j.urology.2018.04.009. Epub 2018 Apr 25.
4
Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: current concepts and controversies.睾丸低危转移性非精原细胞瘤的管理:当前概念与争议
Indian J Urol. 2010 Jan-Mar;26(1):92-7. doi: 10.4103/0970-1591.60449.
5
Canadian consensus guidelines for the management of testicular germ cell cancer.加拿大睾丸生殖细胞癌管理共识指南
Can Urol Assoc J. 2010 Apr;4(2):e19-38. doi: 10.5489/cuaj.815.